ICU专用虚拟现实干预对COVID-19 ICU幸存者心理福祉与生活质量影响的随机对照试验研究方案
BACKGROUND: The SARS-CoV-2 outbreak has resulted in a tremendous increase in hospital and intensive care unit (ICU) admissions all over the world.…
要点
- COVID-19 ICU幸存者易出现PTSD、焦虑抑郁等心理损害并影响生活质量。
- 研究采用ICU专用虚拟现实(ICU-VR)作为ICU后照护干预手段。
- 主要结局为出院后6个月内心理福祉(IES-R、HADS)与生活质量(EQ-5D、RAND-36)。
核心结论
- 该试验旨在评估COVID-19专用ICU-VR能否改善ICU幸存者的心理福祉与生活质量。
- 研究结果将为虚拟现实能否用于特定疾病ICU后照护提供依据。
研究设计与样本
- 多中心随机对照试验,在荷兰鹿特丹四家医院的混合外科ICU开展。
- 早期组于出院后3个月门诊随访时接受ICU-VR,晚期组于出院后6个月接受。
关键数值与推荐
- 主要结局为出院后6个月内心理福祉,采用IES-R与HADS评估。
- 生活质量采用EQ-5D与RAND-36问卷评估。
- 次要目标包括随访至出院后12个月的组内变化与组间差异,以及患者对ICU照护与ICU-VR的满意度与看法。
临床怎么用
- 若证实有效,ICU-VR可作为COVID-19等特定疾病ICU后照护中改善心理福祉与生活质量的干预方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The SARS-CoV-2 outbreak has resulted in a tremendous increase in hospital and intensive care unit (ICU) admissions all over the world. Patients with severe coronavirus disease 2019 (COVID-19) warranting ICU treatment usually have prolonged mechanical ventilation and are expected to be prone to develop psychological impairments, such as post-traumatic stress disorder (PTSD), anxiety and depression, which negatively impact quality of life. To date, no effective treatment strategy is available. In the current trial, we aim to assess the effect of an ICU-specific virtual reality (ICU-VR) intervention on psychological well-being and quality of life after COVID-19 ICU treatment. METHODS: In this multicentre, randomized controlled trial, we aim to examine whether COVID-19-specific ICU-VR, offered 3 months after hospital discharge, improves psychological well-being and quality of life. Secondary objectives are, firstly, to examine the intra-group changes in psychological well-being and quality of life and the inter-group differences in psychological well-being and quality of life during follow-up, up to 12 months after hospital discharge, and secondly, to examine patients' satisfaction with and rating of ICU care and aftercare and patients' perspectives on ICU-VR. Eighty adult patients treated for COVID-19 in the mixed-surgical ICUs of four hospitals in Rotterdam, the Netherlands, will be included and randomized (1:1) to either early or late ICU-VR between June 29 and December 31, 2020. Patients randomized to early ICU-VR will receive the ICU-VR intervention during an outpatient clinic visit 3 months after hospital discharge, whereas patients randomized to late ICU-VR will receive ICU-VR 6 months after hospital discharge. Primary outcomes of this study are psychological well-being, assessed using the Impact of Event Scale-Revised (IES-R) and the Hospital Anxiety and Depression Scale (HADS), and quality of life, assessed using the European Quality of Life 5 Dimensions (EQ-5D) and RAND-36 questionnaires, up to 6 months after hospital discharge. DISCUSSION: Currently, an effective treatment for psychological sequelae after ICU treatment for specific illnesses is unavailable. Results from this study will provide insight whether virtual reality is a modality that can be used in ICU aftercare to improve psychological well-being and quality of life, or satisfaction, after ICU treatment for specific illnesses such as COVID-19. TRIAL REGISTRATION: This trial has been retrospectively registered on the Netherlands Trial Register on August 14, 2020 ( NL8835 ).
引用
- Vlake JH, Van Bommel J, Wils EJ, et al. Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being and quality of life in COVID-19 ICU survivors: a study protocol for a multicentre, randomized controlled trial. Trials. 2021. PMID: 33952318. doi:10.1186/s13063-021-05271-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。